Inventor profile of:

Joseph J. Buggy

City:

Mountain View, California

Country:

United States

Published Applications:

105

Last publication date:

2026-01-15

Top Assignees for applications by Joseph J. Buggy

The entities that hold a legal rights for patent applications filed by inventor Buggy Joseph J.:

Recent patent applications by Buggy Joseph J.

Joseph J. Buggy from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15
US20260014157A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#2 | 2025-04-24
US20250127781A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#3 | 2024-09-26
US20240317756A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#4 | 2024-02-29
US20240065971A1
Human necessities

METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE

#5 | 2023-09-21
US20230293532A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#6 | 2023-08-10
US20230248730A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#7 | 2022-08-11
US20220249494A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#8 | 2022-07-07
US20220213106A1
Chemistry; metallurgy

Inhibitors of Bruton's Tyrosine Kinase

#9 | 2022-06-09
US20220175785A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#10 | 2021-11-25
US20210361657A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#11 | 2021-06-10
US20210169885A1
Human necessities

Use of inhibitors of Brutons tyrosine kinase (Btk)

#12 | 2021-05-20
US20210145835A1
Human necessities

METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER

#13 | 2020-09-17
US20200289515A1
Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS

#14 | 2020-09-03
US20200276199A1
Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS

#15 | 2020-08-06
US20200246259A1
Human necessities

METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE

#16 | 2020-05-28
US20200163968A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#17 | 2020-05-14
US20200147084A1
Human necessities

TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY

#18 | 2020-02-20
US20200055859A1
Chemistry; metallurgy

INHIBITORS OF BRUTONS TYROSINE KINASE

#19 | 2019-11-28
US20190358234A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (BTK)

#20 | 2019-06-20
US20190184196A1
Human necessities

FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF

#21 | 2019-06-06
US20190167687A1
Human necessities

METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER

#22 | 2018-11-01
US20180311153A1
Human necessities

METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE

#23 | 2018-10-04
US20180280395A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#24 | 2018-09-13
US20180256581A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#25 | 2018-07-12
US20180193345A1
Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS

#26 | 2018-03-15
US20180071294A1
Human necessities

Methods for the treatment of HER2 amplified cancer

#27 | 2018-03-15
US20180071293A1
Human necessities

TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY

#28 | 2018-02-08
US20180036313A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#29 | 2018-01-18
US20180015091A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#30 | 2017-12-21
US20170362246A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#31 | 2017-11-23
US20170333731A1
Human necessities

Formulations of histone deacetylase inhibitor and uses thereof

#32 | 2017-09-21
US20170266186A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#33 | 2017-08-31
US20170246169A1
Human necessities

Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors

#34 | 2017-06-01
US20170151243A1
Human necessities

Methods for the treatment of HER2 amplified cancer

#35 | 2017-02-09
US20170035762A1
Human necessities

Use of inhibitors of Bruton'S tyrosine kinase (Btk)

#36 | 2016-11-10
US20160324859A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (BTK)

#37 | 2016-08-25
US20160243033A1
Human necessities

METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE

#38 | 2016-06-23
US20160175312A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#39 | 2016-06-09
US20160160286A1
Chemistry; metallurgy

METHODS FOR DETERMINING CANCER RESISTANCE TO HISTONE DEACETYLASE INHIBITORS

#40 | 2016-01-07
US20160000792A1
Human necessities

Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors

#41 | 2015-11-12
US20150320758A1
Human necessities

SELECTIVE INHIBITORS OF HISTONE DEACTYLASE

#42 | 2015-11-12
US20150320718A1
Human necessities

Hydroxamates as therapeutic agents

#43 | 2015-10-29
US20150307500A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#44 | 2015-10-29
US20150306106A1
Human necessities

Inhibitors of Bruton's tyrosine kinase

#45 | 2015-10-22
US20150299119A1
Chemistry; metallurgy

Indole derivatives as inhibitors of histone deacetylase

#46 | 2015-09-24
US20150265618A1
Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE

#47 | 2015-07-02
US20150184249A1
Chemistry; metallurgy

Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)

#48 | 2015-06-18
US20150164854A1
Human necessities

FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF

#49 | 2015-06-04
US20150152115A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#50 | 2015-05-14
US20150133661A1
Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#51 | 2015-02-12
US20150044217A1
Human necessities

Methods for the treatment of HER2 amplified cancer

#52 | 2015-02-05
US20150038542A1
Chemistry; metallurgy

USES OF SELECTIVE INHIBITORS OF HDAC8 AND TREATMENT OF INFLAMMATORY CONDITIONS

#53 | 2015-01-29
US20150031711A1
Chemistry; metallurgy

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#54 | 2015-01-29
US20150031710A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#55 | 2014-12-18
US20140371241A1
Human necessities

TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY

#56 | 2014-11-20
US20140341989A1
Human necessities

Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof

#57 | 2014-10-09
US20140303191A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#58 | 2014-10-09
US20140301976A1
Human necessities

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

#59 | 2014-07-10
US20140194446A1
Chemistry; metallurgy

Use of inhibitors of bruton's tyrosine kinase (BTK)

#60 | 2014-05-15
US20140134265A1
Human necessities

TEC family kinase inhibitor adjuvant therapy

#61 | 2014-03-20
US20140079690A1
Human necessities

Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumors

#62 | 2014-02-27
US20140057907A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#63 | 2014-02-27
US20140057862A1
Human necessities

Formulations of histone deacetylase inhibitor and uses therof

#64 | 2014-01-02
US20140004174A1
Chemistry; metallurgy

Selective inhibitors of histone deacetylase

#65 | 2013-11-21
US20130310402A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#66 | 2013-10-17
US20130273030A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#67 | 2013-08-08
US20130202611A1
Chemistry; metallurgy

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#68 | 2013-08-01
US20130195852A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#69 | 2013-07-11
US20130178483A1
Chemistry; metallurgy

Methods and Compositions for Inhibition of Bone Resorption

#70 | 2013-06-20
US20130156727A1
Human necessities

Indole derivatives as inhibitors of histone deacetylase

#71 | 2013-06-06
US20130142758A1
Human necessities

Hydroxamates as therapeutic agents

#72 | 2013-03-28
US20130078215A1
Chemistry; metallurgy

USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS

#73 | 2013-02-07
US20130035334A1
Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#74 | 2013-01-17
US20130018060A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#75 | 2012-12-27
US20120329130A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#76 | 2012-11-22
US20120296089A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#77 | 2012-11-01
US20120277255A1
Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#78 | 2012-11-01
US20120277225A1
Chemistry; metallurgy

Inhibitors of Bruton'S tyrosine kinase

#79 | 2012-08-09
US20120202264A1
Chemistry; metallurgy

INHIBITORS OF IL2-INDUCIBLE T-CELL KINASE

#80 | 2012-07-19
US20120184567A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#81 | 2012-07-19
US20120184013A1
Chemistry; metallurgy

Inhibitors of BMX non-receptor tyrosine kinase

#82 | 2012-07-19
US20120183535A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#83 | 2012-07-12
US20120178753A1
Chemistry; metallurgy

Inhibitors of Bruton's tyrosine kinase

#84 | 2012-06-28
US20120165328A1
Chemistry; metallurgy

INHIBITORS OF B LYMPHOCYTE KINASE

#85 | 2012-04-26
US20120101114A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#86 | 2012-04-26
US20120101113A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#87 | 2012-04-26
US20120100138A1
Human necessities

THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#88 | 2012-04-12
US20120087915A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#89 | 2012-03-22
US20120071497A1
Human necessities

METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE

#90 | 2012-03-15
US20120065201A1
Chemistry; metallurgy

INHIBITORS OF BRUTON'S TYROSINE KINASE

#91 | 2012-03-15
US20120064032A1
Human necessities

Hydroxamates as therapeutic agents

#92 | 2011-12-22
US20110311624A1
Human necessities

Formulations of histone deacetylase inhibitor and uses thereof

#93 | 2011-06-23
US20110150825A1
Chemistry; metallurgy

USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS

#94 | 2011-04-07
US20110081409A1
Human necessities

Selective inhibitors of histone deacetylase

#95 | 2011-03-03
US20110053164A1
Chemistry; metallurgy

Methods for determining cancer resistance to histone deacetylase inhibitors

#96 | 2011-01-27
US20110021528A1
Human necessities

Hydroxamates as therapeutic agents

#97 | 2010-11-11
US20100285516A1
Human necessities

CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE

#98 | 2010-10-07
US20100254905A1
Human necessities

Inhibitors of Bruton's tyrosine kinase

#99 | 2009-10-29
US20090270497A1
Human necessities

Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors

#100 | 2009-09-03
US20090220454A1
Human necessities

Hydroxamates as therapeutic agents

InventorID:

42527 ⎘